Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: MICHAEL R WILLIAMS who wrote (2333)	11/10/1998 8:08:00 AM
From: Curtis Frazier	Read Replies (1) \| Respond to of 2911

You mentioned Wellpoint looking at a lot of other software vendors before making their choice. I have to wonder about that. I know a very large financial company that has a sizeable portion on their assets a few years ago on OS/2 Warp. They believed it when someone told them Microsoft was going down and they needed to go with OS2. Sometimes those type of companies the senior management never even consults their own technical people when making technical desicions and they believe the marketeer's of the folks trying to push them their software. I'm not saying this is the case here, but it does happen. Anyway, I doubt if I'll ever even break even on this investment considering I bought in at $8/share when everything was looking rosy then.

To: MICHAEL R WILLIAMS who wrote (2333)	11/10/1998 9:47:00 AM
From: Mike Moran	Read Replies (1) \| Respond to of 2911

Michael, I asked the question about payroll and employees once recently. Cymedix has between 10 and 12 full time employees including its management. That size makes each employee indespensible. That is laughable compared to Healtheon, the competitor you read most about in the press, who boasts 72 programmers. Even if Mr. Netscape Jim Clark works gratis, I'd estimate that 150 Healtheon employees still draw payroll checks. Other competitors such as Synetic and Abaton number their Internet programmers in the 30-40 range, double that for total employees. That makes the Wellpoint agreement all the more outstanding, but points out Cymedix gaping hole. The survival of development stage companies like Cymedix become life and death battles. Before yesterday Cymedix was losing that battle. Not nearly enough money, not nearly enough people. After yestrday they bought some time, but now the stakes are higher. A higher stock price will level the playing field, allow Cymedix to attract new people, give management a reason to stay the course.